NL-OMON51351尚未招募不适用
iving lab smartQare, Sensire and NAAST -
smartQare B.V.0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Being an adult (age 18+)
- •- Receiving home care from Sensire
- •- Suffering from 1 or more chronic conditions (as defined by Centers for
- •Disease Control and Prevention (2021): *conditions that last 6 months or more
- •and require ongoing medical attention or limit activities of daily living or
- •both* and/or a higher risk of falling.
排除标准
- •- Having a history of anxiety disorders
- •- Having severe cognitive impairments
- •- Being unable to independently charge viQtor once a day, put viQtor in or get
- •viQtor out the armband or put viQtor on the upper arm or take it off
- •- Being in acute life-threatening conditions or receiving intensive/palliative
- •- Not physically being able to press the help button on their upper arm
- •- Having cardiac implants
- •- Wearing viQtor for a long time on the upper arm can have negative
- •consequences for the skin or having sensitive skin.
- •- Residing in a location where the ViQtor solution has no connection coverage.
研究者
相似试验
进行中（未招募）
1 期
A single-dose, randomized, two-period, two-sequence, crossover pilot bioequivalence study on formulations containing rivaroxaban and acetylsalicylic acid in healthy volunteers under fasting conditions.CTIS2023-509841-12-00Cepha s.r.o.14
进行中（未招募）
1 期
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Patients with Diabetic Macular Edema Treated with Faricimab (RO6867461) - Altimeter StudyDiabetic Macular Edema, a complication of Diabetic RetinopathyMedDRA version: 20.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853EUCTR2020-001174-30-PLF.Hoffman-La Roche Ltd.80
进行中（未招募）
1 期
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Patients with Diabetic Macular Edema Treated with Faricimab (RO6867461) - Altimeter StudyDiabetic Macular Edema, a complication of Diabetic RetinopathyMedDRA version: 20.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853EUCTR2020-001174-30-HRF.Hoffman-La Roche Ltd.80
进行中（未招募）
1 期
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Patients with Diabetic Macular Edema Treated with Faricimab (RO6867461) - Altimeter StudyDiabetic Macular Edema, a complication of Diabetic RetinopathyMedDRA version: 20.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853EUCTR2020-001174-30-ITF. HOFFMANN - LA ROCHE LTD.80
进行中（未招募）
1 期
A Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naïve Patients with Diabetic Macular Edema Treated with Faricimab (RO6867461) - Altimeter StudyDiabetic Macular Edema, a complication of Diabetic RetinopathyMedDRA version: 20.1Level: LLTClassification code 10057934Term: Diabetic macular edemaSystem Organ Class: 100000004853EUCTR2020-001174-30-DEF.Hoffman-La Roche Ltd.80